Just a moment, the page is loading...

Galderma Laboratories, L.P. Medical Grants Portal

Galderma Laboratories, L.P. (Galderma) recognizes the importance of supporting activities that enhance and develop the knowledge, skill set, and proficiency of healthcare professionals. We are committed to supporting the medical community and advancing the science of skin health to address patients’ needs. We do this through a variety of mechanisms, such as providing medical grants in the form of funding and/or in-kind product, for Medical Education Activities, clinical research activities, and residency program trainings.

Residency Program Training

Galderma Laboratories, L.P. (Galderma) recognizes the importance of supporting residency programs that provide formal and structured on-label injection trainings involving our portfolio of aesthetic injectable products. Results of such activities may lead to greater understanding of the therapeutic areas that we treat, our products and their potential applications, as well as improved patient care.

Galderma accepts unsolicited requests for in-kind product grants from Residency Program Directors at ACGME-accredited dermatology, plastic surgery, ophthalmology, or otolaryngology Academic Institutions who are interested in conducting their own on-label injection trainings.

Galderma is limited to the provision of in-kind product support only. Resident program trainings should be conducted independently from Galderma; therefore, no other support from Galderma will be provided (e.g., trainers, funding, etc.).

Submit a Request

Galderma is interested in Medical Education (ME) Activities that leads to a greater understanding of the therapeutic areas that we treat, our products and their potential applications, as well as improved patient care. Requests for ME Activity support must align with the company’s defined areas of strategic interest. Currently these include:

  • Prescription
    • Acne
    • Rosacea
  • Aesthetics
    • Hyaluronic acid fillers
    • Poly-L-lactic acid (PLLA)
    • Neuromodulators
  • Consumer Skincare
    • Moisturizers
    • Cleansers
    • Acne Medications

For further information on Galderma’s areas of interest, please visit www.nestleskinhealth.com/us.

ACGME-accredited dermatology, plastic surgery, ophthalmology, and otolaryngology residency programs may request in-kind product support.

Each residency program is eligible to submit one (1) request for product per academic year, which constitutes the fall, spring, and summer semesters.

  • The Program Director may submit one (1) request each academic year, which will result in up to three (3) product shipments (1 shipment per semester).
  • If a request is submitted at the end of a semester, or after a semester has completed, shipments will only be provided for the remaining academic semester(s).

Only the aesthetic injectable products listed below are available for request.

  • Dysport® 300 unit vial
  • Restylane® Defyne 1.0 mL syringe
  • Restylane® Refyne 1.0 mL syringe
  • Restylane® Lyft 1.0 mL syringe
  • Restylane® Silk 1.0 mL syringe
  • Restylane-L® 1.0 mL syringe
  • Sculptra® Aesthetic 367.5 mg vial

Each resident is eligible to receive up to two (2) units of each product per semester, except for Restylane® Lyft and Sculptra® Aesthetic, for which we allow up to four (4) units of each product per resident per semester.

For example, a program with 10 residents may request the following quantities of in-kind product for each semester:

  • Dysport® 300U vial – 20 vials
  • Restylane-L® 1 mL syringe – 20 syringes
  • Restylane® Silk 1mL syringe – 20 syringes
  • Restylane® Defyne 1mL syringe – 20 syringes
  • Restylane® Refyne 1mL syringe – 20 syringes
  • Restylane® Lyft 1mL syringe – 40 syringes
  • Sculptra® Aesthetic 367.5 mg vial – 40 vials

Galderma does not provide in-kind product support directly to fellows; however, Residency Program Directors may request additional in-kind product for fellows to attend the resident injection training as a learner.

Galderma will not consider requests in support of the following:

  • Non-ACGME-accredited Residency programs, or programs outside those listed as being eligible;
  • Requests for product to be shipped to a fellow, resident, the Program Coordinator, any physician’s private practice, or a medical facility other than the requesting Academic Institution; or
  • Residency programs outside of the U.S.

In-kind product requests for Residency Program trainings must be submitted through Galderma's Medical Grant's Portal ("Portal"). Requests submitted through any other means will not be accepted.

The steps of the submission process are further detailed below:

  1. Submission: An in-kind product is submitted request through the Portal by a Residency Program Director.
  2. Review: The Request is routed to an internal committee for review and a written notification of the committee’s decision is sent.
  3. Letter of Agreement: If the Request is approved, a Letter of Agreement (LOA) is executed between the Galderma and the Academic Institution and the Activity Provider.
  4. Provision of Support: Once a LOA is executed, Galderma will ship the product. Support from Galderma is contingent upon compliance with the terms and conditions of the LOA.

Please note that changes may occur as we periodically update our Process.

Galderma accepts in-kind product requests from Residency Program Directors on an ongoing basis. However, please note that for requests submitted at the end of a semester, or after a semester has completed, shipments will only be provided for the remaining academic semester(s). Please ensure that requests are submitted with a reasonable amount of time left in the semester for Galderma to review the request, initiate and execute a LOA with your Academic Institution, and the product training to be conducted to use the product.

You will receive a notification email confirming the submission of each request for support.

You may log into the Portal at any time to check the current status of each submitted request.

Once a request is submitted, no changes can be made. However, if the internal committee requires clarification or has questions, a “Request for Additional Information” will be issued.

Galderma requires at least 30 days to review each request. Decisions may take longer if additional information is needed, and additional processing time may also be needed around company and national holidays. Please note that requests may be delayed or declined due to insufficient processing time.

A "Request for Additional Information" is sent to you when additional information is needed in order for the internal committee to make a determination regarding support. If the additional information provided is insufficient or not received in a timely manner, the request may be denied.

Requests for in-kind product must come directly from the Residency Program Director.

  • The Program Director must be a licensed medical doctor (MD) or a doctor of osteopathic medicine (DO) from an ACGME-accredited dermatology, plastic surgery, otolaryngology, or ophthalmology teaching program.
  • The Program Director must have a valid and current state medical license number.

Galderma does not accept Grant Requests from or for individual physicians or groups of physicians.

The following information is required to submit a request for in-kind product:

  • Letter of Request;
  • Activity Description and Agenda;
  • Number of Residents in Program;
  • Proposed Learning Objectives; and
  • Quantity of In-Kind Product Requested From Galderma.

Upon approval of a request, Galderma will enter into a Letter of Agreement (LOA) with the Academic Institution as the Activity Provider. All Medical Education (ME) activities supported by Galderma must abide by the terms of Galderma’s LOA; no other LOAs will be accepted. Galderma may not provide in-kind product support to the Academic Institution until a Letter of Agreement (LOA) has been fully executed. Please note that, the LOA must be executed with a reasonable amount of time left in the semester for the product training to be conducted to use the product. If a reasonable amount of time is not remaining in the semester, product may only be provided for remaining semesters in the academic year.

The LOA requires the Academic Institution to:

  • Retain control over the design and conduct of the Activity;
  • Conduct the Activity independently, without any influence from Galderma;
  • Ensure that the Activity is unbiased, objective, and addresses all relevant treatment options, rather than focusing on a single product;
  • Provide meaningful disclosure to the audience (i.e., disclosure that is reasonably calculated to reach the relevant audience in a manner that will alert them to potential biases) at the beginning of the Activity regarding Galderma’s financial support and acknowledge Galderma as a source of funding for the Activity in any written materials; and
  • Make available a reasonable opportunity for discussion and a question-and-answer session at the end of the Activity.

Product is shipped directly to the Program Director at their Academic Institution only. Product will not be shipped to a resident, the Program Coordinator, any physician’s private practice, or a medical facility other than the requesting Academic Institution.

The exact shipping and delivery dates will be determined by Galderma after an internal review and execution of a LOA between Galderma and the Residency Program Director on behalf of the Academic Institution as the Activity Provider. Deliveries are typically scheduled for Tuesday, Wednesday, or Thursday.

Please be aware that Dysport® has specific temperature requirements for shipping and storing. All efforts should be made to ensure that delivery is intercepted in a timely manner, as replacement product will not be provided if a delivery is missed by the Academic Institution and the product becomes no longer viable. Care should be taken to ensure that Dysport® is protected from light and that temperature control at 2°C–8°C (36°F–46°F) is maintained during shipping and storing.

Please note that some products’ shelf-lives may not extend the duration of the semester. Upon receipt of the product(s), the Residency Program Director shall note the expiration dates and make a reasonable attempt to use all of the products provided. Galderma will not replace products that expire prior to the end of a semester given that enough time was allowed for the residency program to reasonably use the product. Once the product expires or is no longer viable, the Program Director may destroy the product at their own expense.

Galderma is committed to maintaining integrity in all of our professional relationships; we operate under the highest ethical standards and in full compliance with all applicable laws, regulations, industry codes, and guidelines. Approval of funding is never related to or conditioned upon past or future prescriptions or purchases of Galderma products. Furthermore, Galderma does not offer or provide funding to encourage or to reward the prescription, purchase, ordering, or recommending of Galderma products.

Our grant review and approval process is in full accordance with the recommendations and the guidance of the US Food and Drug Administration (FDA), the Accreditation Council for Continuing Medical Education (ACCME), the Office of Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers, the PhRMA Code on Interaction with Health Care Professionals, the AdvaMed Code of Ethics on Interactions with Health Care Providers, and National Physician Payment Transparency Program: Open Payments “Physician Payment Sunshine Act,” as well as internal Galderma policies.

Medical education grant support is never based on or linked to the prescribing, formulary, purchasing, or reimbursement policies or practices of Galderma. In other words, Galderma does not use medical education (ME) grants to generate or reward business from the entity receiving the grant. Galderma does not provide ME grant support as a means to:

  • Give preference to high prescribers or purchasers;
  • Fulfill a customer’s business needs;
  • Respond to a customer’s request for product discounts; and
  • Meet a gap with respect to competitor product pricing.

Furthermore, Galderma also may not receive anything of value in return for providing ME grant support, which includes but is not limited to:

  • The opportunity to select faculty;
  • The opportunity to host a separate Galderma-sponsored meal for the attendees; and
  • The opportunity to design the Activity.

When you submit your application for review, the information you submit will be used for the sole purpose of evaluating your request for support. By submitting materials for review, you agree that the information is not confidential, nor proprietary, and may be referred to a number of different persons at Galderma to determine the level of interest in supporting your request.

If Galderma funds are granted for an ME activity, the source of support must be disclosed to the learners prior to the beginning of the educational activity, in one or more of the following: program brochures, syllabi, and other program materials, and at the time of the activity. This disclosure will not include the use of a trade name, product-group message or commercial interest’s logo. The acknowledgment of commercial support may state the name of the company only.

For live ME activities, you are required to submit details regarding your organizations grantor attendee policy. Should Galderma provide ME grant support, Galderma reserves the right to monitor the Activity at its discretion. Prior to the start date of the Activity, Galderma will notify the Activity Provider if a Galderma representative will be monitoring the Activity. Complimentary access should be given for the entire duration of the Activity. For clarification, this is for observation purposes only; no continuing education credits will be requested by the Galderma designated monitor. If Galderma is not permitted to monitor the Activity, these details should be communicated upfront in the initial request for grant support.

© Galderma 2019 All Rights Reserved. All trademarks are the property of their respective owners.